中国人民解放军总医院第六医学中心中医医学部,北京 100048
齐小荣,女,24岁,硕士研究生。研究方向:中医药防治脑病及内伤杂病。
杨明会,E-mail:ymh9651@sina.com
纸质出版日期:2024-03-25,
收稿日期:2023-11-06,
扫 描 看 全 文
齐小荣,李 敏,谌盈帆,等.补肾活血方对帕金森病模型小鼠肠道功能及血清肠黏膜屏障指标的影响[J].北京中医药,2024,43(3):269-273.
QI Xiaorong,LI Min,CHEN Yingfan,et al.Effects of Bushen Huoxue Recipe on intestinal barrier and intestinal function on Parkinson's disease model mice[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(03):269-273.
齐小荣,李 敏,谌盈帆,等.补肾活血方对帕金森病模型小鼠肠道功能及血清肠黏膜屏障指标的影响[J].北京中医药,2024,43(3):269-273. DOI: 10.16025/j.1674-1307.2024.03.009.
QI Xiaorong,LI Min,CHEN Yingfan,et al.Effects of Bushen Huoxue Recipe on intestinal barrier and intestinal function on Parkinson's disease model mice[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(03):269-273. DOI: 10.16025/j.1674-1307.2024.03.009.
目的
2
探究补肾活血方对帕金森病(PD)模型小鼠肠道功能和肠道屏障的影响。
方法
2
采用随机数字表法将72只C57小鼠分为正常组、模型组、美多芭组、补肾活血方低剂量组(BSHX-L组)、补肾活血方中剂量组(BSHX-M组)和补肾活血方高剂量组(BSHX-H组)6组,每组12只。除正常组外,其余各组均采用腹腔注射1-甲基-4-苯基-1,2,3,6四氢吡啶(MPTP)法制备亚急性PD小鼠模型。BSHX-L组、BSHX-M组、BSHX-H组分别给予0.15、0.3、0.6 g生药/d补肾活血方灌胃,1次/d,连续2周;美多芭组给予美多芭112.5 mg/(kg·d)灌胃,1次/d,连续2周;正常组和模型组予以等量蒸馏水灌胃,1次/d,连续2周。观察比较各组一般情况、行为学检测(旷场总活动距离、旷场活动平均速度和旷场静止时间)、肠道功能(粪便含水量、小肠炭末推进率、24 h排便粒数)、结肠组织病理变化及血清二胺氧化酶(DAO)、D-乳酸(D-LA)水平。
结果
2
与正常组比较,模型组出现精神萎靡,粪粒干硬、排便量下降等,旷场总活动距离短、旷场活动平均速度慢、旷场静止时间长,粪便含水量和小肠炭末推进率低,24 h排便粒数少(
P
<
0.05,
P
<
0.01)。与模型组比较,美多芭组出现行动异常敏捷、打斗次数增多,而补肾活血方各剂量组以上情况均有好转。美多芭组、补肾活血方各剂量组的旷场总活动距离长、旷场活动平均速度快、旷场静止时间短、小肠炭末推进率高,BSHX-H组可见粪便含水量、24 h排便粒数多(
P
<
0.05)。美多芭组和BSHX-L组病理可见炎细胞浸润有所改善,但仍可见肠隐窝结构破坏;而BSHX-M组、BSHX-H组可见肠隐窝表面趋于平整,腺体及肠隐窝结构均有所恢复,且炎细胞浸润程度明显减少。美多芭组和补肾活血方各剂量组血清DAO、D-LA水平均低(
P
<
0.05)。
结论
2
补肾活血方可改善PD模型小鼠的运动状态和肠道功能,减轻结肠组织病理改变及肠黏膜屏障受损。
Objective
2
To investigate the effects of Bushen Huoxue Recipe on intestinal function and intestinal barrier on Parkinson's disease model mice.
Methods
2
72 C57 mice were randomly divided into normal group, model group, Madopar group, Bushen Huoxu Recipe low-dose group (BSHX-L group), Bushen Huoxu Recipe medium-dose group (BSHX-M group) and Bushen Huoxu Recipe high-dose group (BSHX-H group), with 12 mice in each group. Apart from the normal group, mice in other groups were intraperitoneally injected MPTP to induce PD model, BSHX-Lgroup, BSHX-M group and BSHX-H group were given grude herbs with 0.15, 0.3, 0.6 g/d, for two weeks consecutively; Madopar group was given Madopar 112.5mg/(kg·d) intraperitoneally, once a day for two weeks consecutively; the normal group and model group were given distilled water by intragastric administration, once a day for 14 consecutive days. The general condition and behavioral test (total open-pit movement distance, average open-pit movement speed and open-pit static time), intestinal function test (fecal water content, small intestine charcoal powder propulsion rate, and 24 h defecation granule number), the pathological morphology of colon and serum DAO and D-LA levels were detected and compared among the groups.
Results
2
Compared with the blank group, the mice in the model group showed listless spirit, dry and hard stool grains and decreased defecation volume, and the total active distance of open field was significantly reduced, the average active speed of open field was significantly slowed down, and the rest time of open field was significantly prolonged. The fecal water content and small intestine charcoal thrust rate in the model group were significantly decreased. The number of grains in 24 hours of defecation decreased (
P
<
0.05); Compared with the model group, the Metoba group showed abnormal agility and increased fighting times after treatment, while the above conditions were improved after treatment in all Bushen Huoxue Ricipe groups. The total active distance of open field increased significantly, the avera
ge active speed of open field increased, and the rest time of open field decreased in Metoba group and Bushen Huoxue Recipe groups. The rate of small intestine carbon dust advancing in Metoba group increased significantly . Fecal water content and 24-hour defecation granules were increased in Bushen Huoxue Recipe high-dose group (
P
<
0.05), inflammatory cell infiltration was improved in Metoba group and BSHX-L group, but intestinal crypt structure was still damaged. In BSHX-M group and BSHX-H group, the surface of intestinal crypts tended to be flat, the structure of glands and intestinal crypts recovered, and the degree of inflammatory cell infiltration decreased significantly. DAO and D-LA levels in Metoba group and Bushen Huoxue Recipe all dose groups were significantly decreased (all
P
<
0.05).
Conclusion
2
Bushen Huoxue Recipe (tonifying kidney and promoting blood circulation) can significantly improve exercise state and intestinal function of PD model mice, and reduce the damage of colonic tissue structure and intestinal mucosal barrier.
补肾活血方帕金森病肠道功能肠道屏障小鼠
Bushen Huoxue RecipeParkinson's diseaseintestinal functionintestinal barriermice
王少松,李彬,王麟鹏,等.基于“脑肠轴”理论的“调神通腑”针刺法治疗帕金森病思路探讨[J].北京中医药,2023,42(5):532-534.
NAIR AT, RAMACHANDRAN V, JOGHEE NM, et al. Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of parkinson's disease: a critical review[J]. J Neurogastroenterol Motil, 2018,24(1):30-42.
谌盈帆, 栾振先, 李绍旦,等. 补肾活血方对帕金森病模型小鼠TLR4/NF-κB信号通路的影响[J]. 中国中西医结合杂志,2021,41(3):350-355.
李晨, 王鹏, 王亮,等. 补肾活血颗粒对亚急性帕金森病模型小鼠脑黑质多巴胺神经元铁死亡的影响[J]. 中医杂志,2022,63(15):1463-1469.
栾振先,谌盈帆,秦丽,等.基于细胞自噬研究补肾活血方抑制帕金森病模型小鼠α-突触核蛋白集聚的作用[J].中国中西医结合杂志,2020,40(5):602-607.
李明伟, 杨文学, 齐小荣,等. 补肾活血颗粒治疗帕金森病非运动症状的临床研究[J]. 中华保健医学杂志,2023,25(1):24-28.
LANGSTON JW. The MPTP Story[J]. J Parkinsons Dis, 2017,7(S1):11-19.
吕妙君, 冯鹏, 郭雅静,等. 新型肠促胰岛素双受体激动剂对亚急性帕金森病小鼠步态行为的影响及机制研究[J]. 中华老年心脑血管病杂志,2021,23(9):908-912.
陈奇.中药药理研究方法学[M].2版.北京:人民卫生出版社,2006:1167.
张媛,唐启盛,赵瑞珍.颐脑解郁方对脑出血后抑郁大鼠神经再生和修复的影响及机制[J].北京中医药,2023,42(4):414-418.
曾献春, 朱雅琴, 王明明,等. 干酪乳杆菌对便秘小鼠肠道菌群的影响[J]. 食品与发酵工业,2022,48(6):64-70.
于庆洋, 王俊宏. 静宁颗粒调节ADHD大鼠胃肠功能及脑肠肽水平的实验研究[J]. 中医学报,2023,38(5):1047-1052.
刘薇.穴位埋线法治疗便秘型肠易激综合征的临床与实验研究[D].北京:北京中医药大学,2019.
雒晓东, 李哲, 朱美玲,等. 帕金森病(颤拘病)中医临床诊疗专家共识[J]. 中医杂志,2021,62(23):2109-2116.
BRAAK H, DEL TREDICI K, RUB U, et al. Staging of brain pathology related to sporadic Parkinson's disease[J]. Neurobiol Aging, 2003,24(2):197-211.
HOLMQVIST S, CHUTNA O, BOUSSET L, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats[J]. Acta Neuropathol, 2014,128(6):805-820.
郭冰玉,田文杨,张新宁,等.从脑髓-脑神-脑气多角度探讨帕金森病[J].北京中医药,2021,40(8):866-869.
李敏,栾振先,王鹏,等.从“肠-脑轴”角度探讨补肾活血法治疗帕金森病[J].中华中医药学刊,2023,41(6):143-146,270.
杨明会,李军艳,刘毅.系统论引领帕金森病治疗思路[J].医学与哲学(临床决策论坛版),2009,30(2):3-5.
李敏,栾振先,王鹏,等.从“肠-脑轴”角度探讨补肾活血法治疗帕金森病[J].中华中医药学刊,2023,41(6):143-146,270.
李政,李龙文,徐东,等.白藜芦醇对脊髓损伤大鼠的治疗作用与肠道菌群的相关性研究[J].辽宁中医药大学学报,2024,26(1):10-15.
LI KY, WANG JL, XU YY, et al. Intestinal barrier disruption in ileal pouchitis after ileal pouch-anal anastomosis in a rat model[J]. Inflamm Bowel Dis, 2017,23(6):923-931.
张钦畅, 程海波, 沈卫星,等. 基于单细胞转录组测序探讨仙连解毒方对结直肠癌湿热瘀毒证模型小鼠肠道免疫细胞的影响[J]. 中医杂志,2023,64(12):1263-1272.
叶莎莎, 闫俊艳, 肖露,等. 孕期脂多糖诱导的孤独症样大鼠肠道5-羟色胺相关代谢通路的变化[J]. 中国病理生理杂志,2023,39(4):577-587.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构